Hydrolysis, Ligand Exchange, and Redox Properties of Vanadium Compounds: Implications of Solution Transformation on Biological, Therapeutic, and Environmental …
Vanadium is a transition metal with important industrial, technological, biological, and
biomedical applications widespread in the environment and in living beings. The different …
biomedical applications widespread in the environment and in living beings. The different …
Anticancer perspectives of vanadium complexes
Vanadium metal is widely spread in various environments and has essential roles in
biological systems. Vanadium based compounds have been proposed for cancer as a new …
biological systems. Vanadium based compounds have been proposed for cancer as a new …
Vanadium (IV) complexes of salicylaldehyde-based furoic acid hydrazones: Synthesis, BSA binding and in vivo antidiabetic potential
Solution synthesis afforded five novel neutral heteroleptic octahedral paramagnetic
mononuclear oxidovanadium (IV) complexes of general composition [VO (bpy) L], where L is …
mononuclear oxidovanadium (IV) complexes of general composition [VO (bpy) L], where L is …
Ruthenium (II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death
The reaction of the Ru (PPh3) 3Cl2 with HL1− 3− OH (− OH stands for the oxime hydroxyl
group; HL1− OH= diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2− OH …
group; HL1− OH= diacetylmonoxime‐S‐benzyldithiocarbazonate; HL2− OH …
LVVO-Ethyl Maltol-Based Metallodrugs (L2– = Tridentate ONO Ligands): Hydrophobicity, Hydrolytic Stability, and Cytotoxicity via ROS-Mediated Apoptosis
Four new oxidovanadium [VVOL1–4 (ema)] complexes (1–4) have been synthesized using
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …
Fluorescent Diorganotin (IV) Complexes as Anticancer Agents: Study of Cytotoxicity, Cellular Localization, and Mechanism of Cell Death
Three luminescent mixed ligand diorganotin (IV) complexes [Sn2Ph4 (L) 1–3 (DPA)(MeOH)
Cl](where L1=(Z)-N-((E)-3-ethoxy-2-hydroxybenzylidene) isonicotinohydrazonic acid, L2=(Z) …
Cl](where L1=(Z)-N-((E)-3-ethoxy-2-hydroxybenzylidene) isonicotinohydrazonic acid, L2=(Z) …
A Vanadium (V) complexes derived from pyridoxal/salicylaldehyde. Interaction with CT-DNA/HSA, and molecular docking assessments
LP Fioravanço, JB Pôrto, FM Martins… - Journal of Inorganic …, 2023 - Elsevier
With the increasing development of metallopharmaceuticals, coordination compounds
become viable alternatives for therapeutic uses. Despite the importance of platinum …
become viable alternatives for therapeutic uses. Despite the importance of platinum …
A highly selective Schiff base fluorescent sensor for Zn2+, Cd2+ and Hg2+ based on 2, 4-dinitrophenylhydrazine derivative
In pharmacological, environmental, biological, and material research, the design and
synthesis of new fluorescence chemosensors based on Schiff base derivatives are crucial …
synthesis of new fluorescence chemosensors based on Schiff base derivatives are crucial …
Halogenated non-innocent vanadium (V) Schiff base complexes: chemical and anti-proliferative properties
AA Haase, SA Markham, HA Murakami… - New Journal of …, 2024 - pubs.rsc.org
A series of non-innocent halogen substituted Schiff base vanadium catecholates were
added with different electron donating and withdrawing substituents on the catecholates to …
added with different electron donating and withdrawing substituents on the catecholates to …
Insights into the Theranostic Activity of Nonoxido VIV: Lysosome-Targeted Anticancer Metallodrugs
Develo** new anticancer agents can be useful, with the ability to diagnose and treat
cancer worldwide. Previously, we focused on examining the effects of nonoxidovanadium …
cancer worldwide. Previously, we focused on examining the effects of nonoxidovanadium …